Panacea Biotec Ltd PANACEABIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 143.13
- Day Range
- INR 137.84–144.80
- 52-Week Range
- INR 112.35–202.50
- Bid/Ask
- INR 138.83 / INR 138.83
- Market Cap
- INR 8.50 Bil
- Volume/Avg
- 377,998 / 153,996
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,295
- Website
- https://www.panaceabiotec.com
Comparables
Valuation
|
Metric
|
PANACEABIO
|
500660
|
506820
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 65.95 | 109.95 |
Price/Book Value | 1.01 | 24.04 | 24.20 |
Price/Sales | 1.53 | 12.48 | 13.30 |
Price/Cash Flow | — | 82.72 | 110.80 |
Price/Earnings
PANACEABIO
500660
506820
Financial Strength
|
Metric
|
PANACEABIO
|
500660
|
506820
|
|---|---|---|---|
Quick Ratio | 0.80 | 1.45 | 1.90 |
Current Ratio | 1.57 | 1.84 | 2.61 |
Interest Coverage | 1.41 | 417.04 | 183.84 |
Quick Ratio
PANACEABIO
500660
506820
Profitability
|
Metric
|
PANACEABIO
|
500660
|
506820
|
|---|---|---|---|
Return on Assets (Normalized) | −2.05% | 19.44% | 15.60% |
Return on Equity (Normalized) | −3.06% | 38.93% | 25.27% |
Return on Invested Capital (Normalized) | −2.70% | 35.79% | 25.15% |
Return on Assets
PANACEABIO
500660
506820
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Rfhqjjtm | Vkgr | $628.7 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Vmpmbkwb | Mnmkfq | $121.4 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vkmwdmnxn | Cxvmz | $112.8 Bil | |||
| Moderna Inc
MRNA
| Hsdndhdd | Cwyl | $45.3 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Kqbglbk | Dtkqrx | $31.5 Bil | |||
| argenx SE ADR
ARGX
| Scqqxdmf | Vyykf | $25.9 Bil | |||
| BioNTech SE ADR
BNTX
| Mkrxbpxb | Cfxk | $19.2 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hdnxxcgx | Rbkczb | $15.4 Bil | |||
| United Therapeutics Corp
UTHR
| Nrjwxwkhf | Kppk | $14.0 Bil | |||
| Royalty Pharma PLC Class A
RPRX
| Vrsbrvvqw | Jmqxhm | $11.7 Bil |